EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 2 (Hits 1 to 20 of 25)
ID
Country
PT provider
PT scheme
Last changed
705734 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation [EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ] Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation [EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ] 2020-09-10
PT name (Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation)
Scheme name in national language (EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação)

705717 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)] Clinical PT - Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)] 2020-09-10
PT name (Clinical PT - Molecular Biology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2))
Tested property (Coronavírus (SARS-CoV2))

705752 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - TLR Coronavírus (SARS-CoV2): antigen [EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno] Clinical PT - TLR Coronavírus (SARS-CoV2): antigen [EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno] 2020-09-10
PT name (Clinical PT - TLR Coronavírus (SARS-CoV2): antigen)
Scheme name in national language (EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno)
Tested property (Coronavírus (SARS-CoV2))

705758 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] 2020-09-10
PT name (Clinical PT - TLR Immunology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2))

790103 Australia RCPAQAP RCPAQAP Coronavirus SARS CoV-2 Antibodies Coronavirus SARS CoV-2 Antibodies 2020-10-27
PT name (Coronavirus SARS CoV-2 Antibodies)
Tested property (SARS CoV-2)

143893 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Cosmetics and Toiletries Scheme (COSMETICS) Cosmetics and Toiletries Scheme (COSMETICS) 2021-02-25
Test item (Quality of hand sanitizer -NEW 2021 - relevant to SARS-CoV-2) (Quality of face masks -NEW 2021 - relevant to SARS-CoV-2)
Tested property (Relevant to SARS-CoV-2 pandemic) (Relevant to SARS-CoV-2 pandemic)

138199 United States Collaborative Testing Services Collaborative Testing Services CTS Agriculture Laboratory Proficiency (ALP) Program: Water CTS Agriculture Laboratory Proficiency (ALP) Program: Water 2019-05-23
Tested property (Sum Cations, SAR, ADJ-SAR)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-02-25
Test item (Surface testing (swab rinsate) for SARS-CoV-2 molecular)
Tested property (SARS-CoV-2)

690914 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 2020-09-16
PT name (Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112)

690909 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) 2020-06-09
PT name (ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease))
Tested property (Requirements, testing, marking for COVID-19)

807218 Brazil QLM Inovações Tecnológicas QLM Inovações Tecnológicas Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] 2020-11-23
Tested property (SAR)

696054 Germany DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149) [Medical face masks (EN 14683) / filtering half masks (EN 149)] Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149) [Medical face masks (EN 14683) / filtering half masks (EN 149)] 2020-12-18
Remarks (PT relevant to SARS-CoV-2 virus / COVID-19)

789737 Australia RCPAQAP RCPAQAP Molecular Coronavirus SARS-CoV-2 Molecular Coronavirus SARS-CoV-2 2020-10-28
PT name (Molecular Coronavirus SARS-CoV-2)
Tested property (Coronavirus SARS-CoV2)

789879 Australia RCPAQAP RCPAQAP Molecular Respiratory Pathogens Molecular Respiratory Pathogens 2020-10-28
Tested property (Coronavirus (OC43, NL63, SARS-CoV-2))

820055 United Kingdom INSPEC International Limited INSPEC International Limited Personal Protective Equipment [Personal Protective Equipment] Personal Protective Equipment [Personal Protective Equipment] 2021-01-18
Related legislation or standard (European PPE Regulation (EU 2016/425) National legislation regarding PPE for Covid-19)

794057 Australia RCPAQAP RCPAQAP PHLN: SARS-CoV-2 and other coronaviruses PHLN: SARS-CoV-2 and other coronaviruses 2020-10-23
PT name (PHLN: SARS-CoV-2 and other coronaviruses)
Remarks (Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2. Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.)
Tested property (Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated))

790376 Australia RCPAQAP RCPAQAP PoCT: COVID-19 serology (IgG/IgM) PoCT: COVID-19 serology (IgG/IgM) 2020-10-26
PT name (PoCT: COVID-19 serology (IgG/IgM))
Tested property (COVID-19 Serology)

883284 Thailand Department of Medical Sciences PT provider (DMSc PT provider) Department of Medical Sciences PT provider (DMSc PT provider) SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] 2021-07-18
PT name (SARS-CoV-2 detection by Real-time RT-PCR)
Scheme name in national language (SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข))

824901 Germany Reference Institute for Bioanalytics Reference Institute for Bioanalytics SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] 2021-02-16
PT name (SARS-CoV-2 Immunology)
Scheme name in national language (SARS-CoV-2 Immunologie)
Tested property (Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2020-10-01
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

Page 1 of 2 (Hits 1 to 20 of 25)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21